Bostal Pharma

Bostal Pharma is a global specialty pharmaceutical company specializing in advanced drug delivery technologies, with a focus on long-acting injectable (LAI) formulations and complex oral dosage forms. Founded by Dr. Ron Liu, the company operates through Bostal LLC in the United States (formerly AustarPharma) and Guangzhou Bostal Drug Delivery Co., Ltd. in China. Bostal utilizes its proprietary technology platforms—Zpheres™ (microspheres), Geleepot™ (in-situ gel), and Kriztols™ (nanocrystals)—to develop a robust pipeline of 505(b)(2) and generic products targeting neuropsychiatric, metabolic, and cardiovascular diseases. The company's clinical-stage pipeline includes long-acting versions of semaglutide, brexpiprazole, and cariprazine, several of which are currently in Phase 1 clinical trials. In addition to its internal drug development, Bostal provides "one-stop" CDMO services, leveraging its FDA- and EU-approved manufacturing facilities in New Jersey and Guangzhou. The company is committed to improving patient adherence and clinical outcomes by transforming proven molecules into next-generation therapies with enhanced delivery profiles.